The primary objective of this quality improvement project was to measure and reduce the number of oxycodone immediate-release tablets dispensed to overnight stay surgical patients at discharge. The secondary objective was to reduce the proportion of inappropriate oxycodone immediate-release prescriptions at discharge. Interrupted time series analysis was performed in four surgical wards of St Vincent's Public Hospital, Sydney. The baseline period was from January 2005 to August 2013. Interventions and followup occurred until July 2017. Baseline audit of oxycodone immediate-release tablet numbers showed prescribing increased significantly with a monthly linear trend of 1.8 (95%CI = 1.4-2.3; p = 0.001) tablets/100 surgical admissions from January 2005 to August 2013. Four sequential interventions produced no significant change in the primary objective. At the end of the first month of a fifth intervention, comprising audit-feedback plus individual academic detailing, the average number of oxycodone tablets decreased by 77 (95%CI 39-115) tablets/100 surgical cases, and the postintervention linear trend was a monthly reduction of 3.2 (coefficient À3.2 (95%CI À4.5 to À1.8); p = 0.001) tablets/100 surgical admissions. Baseline audit showed 27% of oxycodone prescriptions to be inappropriate. Following our intervention, this dropped to 17% (p = 0.048), and then to 10% (p = 0.002) after 3 years.
Introduction
The rise in the consumption of prescription opioids in the USA and related harm has been well documented [1] [2] [3] . In Australia, oxycodone prescribing has increased by 562% in 11 years as part of a large overall increase in consumption of opioids [4] . Accidental deaths from oxycodone, morphine, codeine, fentanyl, pethidine and tramadol in Australia reached 788 in 2016, rising in parallel with the increase in supply and at a more rapid rate in regional areas than major metropolitan centres [5] . The New Zealand Health Quality and Safety Commission has shown that, although general practitioners prescribe the majority of all opioids, 50% of all patients receiving opioids in the community were commenced in a public hospital setting following a 'trigger' event such as surgery [6] . We have previously shown that, in opioid-na€ ıve patients, surgery was a gateway to persistent opioid use, with the rate of persistent use at > 90 days in opioid-na€ ıve patients 23.6%
after spinal surgery and 13.7% after orthopaedic surgery [7] . This is despite poor evidence of efficacy for long-term opioids in chronic non-cancer pain and abundant evidence of harm.
There is an association between the amount of opioid supplied at initial prescription and an increase in long-term opioid use [8] . Moreover, having an excess of opioids available at home may have adverse consequences.
Approximately one-third of patients who were prescribed opioids on discharge did not use them at all and those who did only used approximately one-third [9] [10] [11] . Once dispensed, patients are reluctant to dispose of these drugs, and excess opioid supply at home may lead to intentional or accidental diversion. Availability of opioids from a previous pain episode may also increase the likelihood of patients using these supplies as first-line analgesia for painful conditions where early opioid use is discouraged, for example, low back pain or headache. In addition, in those describing the illicit use of prescription opioids 55% described obtaining them from family and friends [12] . For this reason, strategies to reduce inappropriate dispensing of opioids after surgery are useful in reducing adverse consequences in the community as well as for the individual.
Discharge prescriptions, particularly in the public sector, are often the responsibility of junior hospital doctors.
Patients leaving hospital go from a highly regulated environment for dosing, to being handed a box of potent opioids when they depart. They are then left to wean their analgesics, often with little guidance. Discharge letters with information about opioids may not reach the general practitioner in time to be useful for the first visit or the patient may not have a regular general practitioner. A previous study in an Australian emergency department used a brief educational interview with prescribers to alter opioid prescribing behaviour and follow-up information at discharge. One hundred and sixty-one patient discharge prescribing episodes were followed up after 3-7 days with significant changes in prescribing, but sustainability was not examined [13] . Our quality improvement project was prompted by concerns raised by the hospital pharmacists who noted a marked increase in the pharmacist hours required for the two-person process of dispensing discharge opioids, most notably oxycodone immediate release. Our study aimed to reduce the total number of oxycodone immediate-release tablets dispensed at discharge and to increase the proportion of appropriate oxycodone prescriptions dispensed at discharge.
Methods
The study was a quality improvement project conducted in All oxycodone immediate-release tablets dispensed for discharge from the surgical wards were included. The use of slow-release opioids for acute pain is actively discouraged within the hospital, and dispensing figures are low, hence the focus on immediate-release opioids for this quality improvement project.
Our secondary objective was to measure and reduce the proportion of inappropriate oxycodone prescriptions dispensed to surgical patients upon discharge.
Inappropriate oxycodone prescription on discharge was defined as a prescription given despite no oxycodone being used by the patient in the 24-h period before discharge and two doses or less of oxycodone used in the 48 h before discharge and no concurrent use of regular paracetamol and/or non-steroidal anti-inflammatory drugs or cyclo-oxygenase-2 inhibitors before and on discharge. A quality improvement cycle was devised to achieve the desired outcomes ( Fig. 1 ). Sequential interventions, 1-5, were introduced and the monthly audit data of the number of oxycodone tablets dispensed measured until a statistically significant change in this number occurred. At this point, the intervention that was associated with that change was adopted on an ongoing basis.
Intervention cycle number 1
An opioid education pamphlet was produced by the Pain Medicine Department with information related to expectations of pain, use of opioids, weaning and disposal.
This was given to patients attending the pre-admission clinic. The chronic pain nurse conducted education sessions for surgical ward nurses including information on how to instruct patients about opioid weaning and disposal at the time of discharge. Anaesthetic department meetings and junior medical officer group teaching sessions were held to educate both groups about safe opioid prescribing. A pain medicine trainee followed up patients with complex postoperative pain after discharge from the acute pain service, to oversee weaning of opioids and discharge planning.
Intervention cycle number 2
All patients seen by the Acute Pain Service had an analgesic discharge plan entered into the electronic discharge summary. The plan included specific instructions about analgesic medications to be supplied for discharge. This plan was visible to the junior medical officer when writing the discharge summary. The plan was written in layman's language and a written copy handed to the patient by the nurse at the time of discharge. A copy was also sent to the general practitioner if the patient had listed one.
Intervention cycle number 3
A letter was printed in the weekly electronic junior medical officer bulletin at the commencement of each term. This letter detailed the increase in prescribing of opioids at the point of discharge from the hospital, the potential consequences and education about prescribing for surgical patients at the point of discharge.
Intervention cycle number 4
Hospital pharmacists were provided with the appropriateness guidelines as listed above. They were asked to call junior medical officers when an oxycodone discharge prescription was inappropriate based on that definition.
Intervention cycle number 5
The i.Pharmacy software was used to produce a Opioid education pamphlet given to patients at preadmission clinic. Group education of nurses, junior medical officers and anaesthetists. Pain trainee supervises weaning and discharge for complex patients.
Analgesic discharge plan entered into the electronic discharge summary by the Acute Pain Service with specific instructions regarding discharge opioids.
Educational letter regarding appropriate discharge opioid prescribing in the junior medical officer electronic bulletin at the beginning of each rotation.
Hospital pharmacist provided with 'appropriateness guideline' so that junior medical officers can be requested to review a discharge prescription if it is outside the guideline.
Individual scripted academic detailing session with a consultant anaesthetist or pain medicine specialist plus individual audit feedback of opioid prescribing. Delivered to each surgical junior medical officer at surgical rotation commencement. Segmented least squares regression models were fitted to the monthly time series data, to obtain parameters for intercept, baseline trend and changes in level and trend after each intervention [14] . We used the Cumby-Huizinga general test for autocorrelation [15] in the previous 12 months and found significant autocorrelation in the previous 2 months. Therefore, an autocorrelation structure of 2 months was chosen. The proportion of inappropriate oxycodone prescription at each point was compared with the pre-intervention baseline period as a reference, using a two-sample test of proportions.
Results
The time series dataset comprised 104 months before the audit intervention and 11 months and 35 months before and after intervention number 5, respectively (Fig. 2) . Parameter estimates from the segmented regression model are given in Table 1 . The starting level of oxycodone prescribed in were for oxycodone. During this period, 38 (27.7%) oxycodone prescriptions were judged to be inappropriate using the criteria defined in the methods (Table 2 ). In the next 6-week sampling period, the number of inappropriate oxycodone prescriptions was 39 (22.6%). In the 6 weeks Figure 3 To examine whether a reduction in oxycodone prescribing was associated with a concurrent equal increase in the dispensing of other immediate-release opioids, the pharmacy generated a monthly report for tramadol 50 mg (squares) and paracetamol 500 mg/codeine 30 mg (triangles). Monthly tablets dispensed per 100 surgical cases are shown with oxycodone 5 mg immediate release (circles) for comparison.
encouraging results [17] . However, more recently, the USA has demonstrated that once population demand for, and dependence on opioids is generated by high supply of prescription opioids, illicit supply chains will substitute if legal supply is reduced. Deaths from prescription opioids in the USA are now levelling off (at very high levels) but deaths from illicit opioids have increased at an even more rapid rate [3] . Other countries such as Australia need to prevent the development of such a high level of population demand before we reach those levels.
Changing prescribing behaviour, however, can be a difficult process. A 2006 systematic review of 235 randomised, controlled trials of guideline dissemination and implementation strategies showed that the majority of comparisons (86.6%) observed some improvements in the desired outcome, but the magnitude of change was usually small. Improvements in care ranged from an average of 14.1% for reminders, 8.1% for the dissemination of educational materials, 7.0% for audit and feedback and 6.0% for multifaceted interventions involving educational outreach [18] .
Provision of printed material in an attempt to change prescriber behaviour is simple but has been thought to have limited or no efficacy [19] . This has indeed been the case for opioid reduction pamphlets, except in the area of opioid disposal which is more amenable to simple interventions [20, 21] . A pamphlet outlining methods for and importance of opioid disposal is, therefore, a way of reducing the availability of excess opioids for subsequent misuse or diversion even if oversupply occurs, with disposal of unused opioid improving from 5% to 27% in one study [20] . 
